174 related articles for article (PubMed ID: 23832770)
21. Aspirin-induced blockade of NF-kappaB activity restrains up-regulation of glial fibrillary acidic protein in human astroglial cells.
Bae MK; Kim SR; Lee HJ; Wee HJ; Yoo MA; Ock Oh S; Baek SY; Kim BS; Kim JB; Sik-Yoon ; Bae SK
Biochim Biophys Acta; 2006 Mar; 1763(3):282-9. PubMed ID: 16516312
[TBL] [Abstract][Full Text] [Related]
22. Drug screening to identify suppressors of GFAP expression.
Cho W; Brenner M; Peters N; Messing A
Hum Mol Genet; 2010 Aug; 19(16):3169-78. PubMed ID: 20538881
[TBL] [Abstract][Full Text] [Related]
23. GFAP promoter drives Müller cell-specific expression in transgenic mice.
Kuzmanovic M; Dudley VJ; Sarthy VP
Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3606-13. PubMed ID: 12882814
[TBL] [Abstract][Full Text] [Related]
24. Multiple signaling pathways converge to regulate bone-morphogenetic-protein-dependent glial gene expression.
Dore JJ; DeWitt JC; Setty N; Donald MD; Joo E; Chesarone MA; Birren SJ
Dev Neurosci; 2009; 31(6):473-86. PubMed ID: 19325229
[TBL] [Abstract][Full Text] [Related]
25. Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance.
Tanaka KF; Takebayashi H; Yamazaki Y; Ono K; Naruse M; Iwasato T; Itohara S; Kato H; Ikenaka K
Glia; 2007 Apr; 55(6):617-31. PubMed ID: 17299771
[TBL] [Abstract][Full Text] [Related]
26. Elevated blood pressure in transgenic mice with brain-specific expression of human angiotensinogen driven by the glial fibrillary acidic protein promoter.
Morimoto S; Cassell MD; Beltz TG; Johnson AK; Davisson RL; Sigmund CD
Circ Res; 2001 Aug; 89(4):365-72. PubMed ID: 11509454
[TBL] [Abstract][Full Text] [Related]
27. Neurons induce GFAP gene promoter of cultured astrocytes from transgenic mice.
Gomes FC; Garcia-Abreu J; Galou M; Paulin D; Moura Neto V
Glia; 1999 Apr; 26(2):97-108. PubMed ID: 10384875
[TBL] [Abstract][Full Text] [Related]
28. Modified GFAP promoter auto-regulates tet-activator expression for increased transactivation and reduced tTA-associated toxicity.
Barton MD; Dunlop JW; Psaltis G; Kulik J; DeGennaro L; Kwak SP
Brain Res Mol Brain Res; 2002 May; 101(1-2):71-81. PubMed ID: 12007834
[TBL] [Abstract][Full Text] [Related]
29. A NF-kappa B/Sp1 region is essential for chromatin remodeling and correct transcription of a human granulocyte-macrophage colony-stimulating factor transgene.
Cakouros D; Cockerill PN; Bert AG; Mital R; Roberts DC; Shannon MF
J Immunol; 2001 Jul; 167(1):302-10. PubMed ID: 11418664
[TBL] [Abstract][Full Text] [Related]
30. Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia.
Zhang W; Potrovita I; Tarabin V; Herrmann O; Beer V; Weih F; Schneider A; Schwaninger M
J Cereb Blood Flow Metab; 2005 Jan; 25(1):30-40. PubMed ID: 15678110
[TBL] [Abstract][Full Text] [Related]
31. DREAM mediates cAMP-dependent, Ca2+-induced stimulation of GFAP gene expression and regulates cortical astrogliogenesis.
Cebolla B; Fernández-Pérez A; Perea G; Araque A; Vallejo M
J Neurosci; 2008 Jun; 28(26):6703-13. PubMed ID: 18579744
[TBL] [Abstract][Full Text] [Related]
32. Glial fibrillary acidic protein expression and promoter activity in the inner ear of developing and adult mice.
Rio C; Dikkes P; Liberman MC; Corfas G
J Comp Neurol; 2002 Jan; 442(2):156-62. PubMed ID: 11754168
[TBL] [Abstract][Full Text] [Related]
33. A novel polymorphic AP-1 binding element of the GFAP promoter is associated with different allelic transcriptional activities.
Bachetti T; Di Zanni E; Lantieri F; Caroli F; Regis S; Filocamo M; Rainero I; Gallone S; Cilia R; Romano S; Savoiardo M; Pareyson D; Biancheri R; Ravazzolo R; Ceccherini I
Ann Hum Genet; 2010 Nov; 74(6):506-15. PubMed ID: 20946255
[TBL] [Abstract][Full Text] [Related]
34. Astrocyte expression of a dominant-negative interferon-gamma receptor.
Hindinger C; Gonzalez JM; Bergmann CC; Fuss B; Hinton DR; Atkinson RD; Macklin WB; Stohlman SA
J Neurosci Res; 2005 Oct; 82(1):20-31. PubMed ID: 16118798
[TBL] [Abstract][Full Text] [Related]
35. Expression specificity of GFAP transgenes.
Su M; Hu H; Lee Y; d'Azzo A; Messing A; Brenner M
Neurochem Res; 2004 Nov; 29(11):2075-93. PubMed ID: 15662842
[TBL] [Abstract][Full Text] [Related]
36. Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter.
Wang CY; Wang S
Gene Ther; 2006 Oct; 13(20):1447-56. PubMed ID: 16724097
[TBL] [Abstract][Full Text] [Related]
37. Chromatin accessibility at a STAT3 target site is altered prior to astrocyte differentiation.
Urayama S; Semi K; Sanosaka T; Hori Y; Namihira M; Kohyama J; Takizawa T; Nakashima K
Cell Struct Funct; 2013; 38(1):55-66. PubMed ID: 23439558
[TBL] [Abstract][Full Text] [Related]
38. hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo.
Zhuo L; Theis M; Alvarez-Maya I; Brenner M; Willecke K; Messing A
Genesis; 2001 Oct; 31(2):85-94. PubMed ID: 11668683
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow-derived cells expressing green fluorescent protein under the control of the glial fibrillary acidic protein promoter do not differentiate into astrocytes in vitro and in vivo.
Wehner T; Böntert M; Eyüpoglu I; Prass K; Prinz M; Klett FF; Heinze M; Bechmann I; Nitsch R; Kirchhoff F; Kettenmann H; Dirnagl U; Priller J
J Neurosci; 2003 Jun; 23(12):5004-11. PubMed ID: 12832523
[TBL] [Abstract][Full Text] [Related]
40. Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector--potential glioblastoma targeting.
McKie EA; Graham DI; Brown SM
Gene Ther; 1998 Apr; 5(4):440-50. PubMed ID: 9614567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
